Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gilead Sciences
Pharma
Ipsen touts early launch results for liver disease drug Iqirvo
Ipsen’s Iqirvo is off to a solid launch as it battles with two other drugs to treat patients with the rare liver disease primary biliary cholangitis.
Kevin Dunleavy
Apr 17, 2025 8:47am
Gilead reprimanded over conference Wi-Fi sponsorship
Apr 14, 2025 9:40am
California cuts: Gilead lays off 149, Roche eliminates 108 jobs
Apr 7, 2025 3:29pm
Gilead bumps CEO Daniel O'Day's compensation package to $23.7M
Mar 28, 2025 10:47am
Potential US budget cuts have limited impact on Gilead: analysts
Mar 26, 2025 2:47pm
Gilead's PrEP shows early promise in once-yearly dosing
Mar 11, 2025 2:30pm
